Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 11;30(7):6623-6633.
doi: 10.3390/curroncol30070486.

The Impact of Frailty on Palliative Care Receipt, Emergency Room Visits and Hospital Deaths in Cancer Patients: A Registry-Based Study

Peter Strang  1   2 , Torbjörn Schultz  2
Affiliations

The Impact of Frailty on Palliative Care Receipt, Emergency Room Visits and Hospital Deaths in Cancer Patients: A Registry-Based Study

Peter Strang et al. Curr Oncol. .

Abstract

Background: Eastern Cooperative Oncology Group (ECOG) performance status is used in decision-making to identify fragile patients, despite the development of new and possibly more reliable measures. This study aimed to examine the impact of frailty on end-of-life healthcare utilization in deceased cancer patients.

Method: Hospital Frailty Risk Scores (HFRS) were calculated based on 109 weighted International Classification of Diseases 10th revision (ICD-10) diagnoses, and HFRS was related to (a) receipt of specialized palliative care, (b) unplanned emergency room (ER) visits during the last month of life, and (c) acute hospital deaths.

Results: A total of 20,431 deceased cancer patients in ordinary accommodations were studied (nursing home residents were excluded). Frailty, as defined by the HFRS, was more common in men than in women (42% vs. 38%, p < 0.001) and in people residing in less affluent residential areas (42% vs. 39%, p < 0.001). Patients with frailty were older (74.1 years vs. 70.4 years, p < 0.001). They received specialized palliative care (SPC) less often (76% vs. 81%, p < 0.001) but had more unplanned ER visits (50% vs. 35%, p < 0.001), and died more often in acute hospital settings (22% vs. 15%, p < 0.001). In multiple logistic regression models, the odds ratio (OR) was higher for frail people concerning ER visits (OR 1.81 (1.71-1.92), p < 0.001) and hospital deaths (OR 1.66 (1.51-1.81), p < 0.001), also in adjusted models, when controlled for age, sex, socioeconomic status at the area level, and for receipt of SPC.

Conclusion: Frailty, as measured by the HFRS, significantly affects end-of-life cancer patients and should be considered in oncologic decision-making.

Keywords: cancer; cancer care transitions; emergency service; frailty; palliative care services; place of death.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., Carbone P.P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 1982;5:649–655. doi: 10.1097/00000421-198212000-00014. - DOI - PubMed
    1. Simcock R., Wright J. Beyond Performance Status. Clin. Oncol. 2020;32:553–561. doi: 10.1016/j.clon.2020.06.016. - DOI - PMC - PubMed
    1. Schulkes K.J., Hamaker M.E., van den Bos F., van Elden L.J. Relevance of a Geriatric Assessment for Elderly Patients With Lung Cancer—A Systematic Review. Clin. Lung Cancer. 2016;17:341–349.e3. doi: 10.1016/j.cllc.2016.05.007. - DOI - PubMed
    1. Cheng S., Qureshi M., Pullenayegum E., Haynes A., Chan K.K. Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis. ESMO Open. 2017;2:e000225. doi: 10.1136/esmoopen-2017-000225. - DOI - PMC - PubMed
    1. Butaney M., Satkunasivam R., Goldberg H., Freedland S.J., Patel S.P., Hamid O., Pal S.K., Klaassen Z., Wallis C.J.D. Analysis of Heterogeneity in Survival Benefit of Immunotherapy in Oncology According to Patient Demographics and Performance Status: A Systematic Review and Meta-Analysis of Overall Survival Data. Am. J. Clin. Oncol. 2020;43:193–202. doi: 10.1097/COC.0000000000000650. - DOI - PubMed

Publication types